2007

1. First-line treatment with vinorelbine (VNR) plus carboplatin (CBDCA) for patients with advanced non-small-cell lung cancer (NSCLC): MAP4/OP18 mRNA expression as marker predictive of response

   EJC SUPPLEMENTS